|
[1]
|
Mogi, M., Hoshide, S. and Kario, K. (2024) Consider Hypertension Risk Factors Once Again. Hypertension Research, 47, 1443-1444. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Won, H., Bae, J.H., Lim, H., Kang, M., Kim, M. and Lee, S. (2024) 2024 KSoLA Consensus on Secondary Dyslipidemia. The Korean Journal of Internal Medicine, 39, 717-730. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
胡佳琪, 陈新洋, 刘明月, 等. 钢铁工人内脏型肥胖相关指标与高血压、糖尿病和血脂异常共病的相关性[J]. 现代预防医学, 2025, 52(8): 1372-1378+1417.
|
|
[4]
|
沈益妹, 章奇, 俞梅华, 等. 肥胖和中心性肥胖高血压控制不良患者合并血脂异常、糖尿病和高尿酸血症的分析[J]. 中国卫生检验杂志, 2023, 33(3): 327-331.
|
|
[5]
|
Wang, F.H., et al. (2025) Interaction of Obesity and Dyslipidemia on the Risk of Hypertension. China Medical Abstracts (Internal Medicine), 42, 27.
|
|
[6]
|
刘梽颍, 谢孟岐, 开赛·艾尼瓦尔, 等. 基于随机森林模型探讨PLCL2基因多态性与LAA型缺血性脑卒中发病风险预测[J]. 现代医学, 2025, 53(7): 1025-1031.
|
|
[7]
|
王凤华, 王雄关, 王晶, 等. 甘油三酯-葡萄糖乘积指数与全身性肥胖及中心性肥胖对高血压患病的交互作用[J]. 中国慢性病预防与控制, 2025, 33(7): 481-486.
|
|
[8]
|
席朋林. 保定市C社区中老年居民高血压、糖尿病、高血脂、高尿酸血症患病情况及影响因素分析[D]: [硕士学位论文]. 保定: 河北大学, 2024.
|
|
[9]
|
胡建功, 张梅, 孔超, 等. 中国居民身体活动水平与高血压、糖尿病和血脂异常的关系分析[J]. 中国慢性病预防与控制, 2024, 32(2): 90-94+99.
|
|
[10]
|
刘若男, 辛义忠, 李岩. 基于皮尔逊相关系数的动态签名验证方法[J]. 仪器仪表学报, 2022, 43(7): 279-287.
|
|
[11]
|
董虹孛, 熊静帆, 程红, 等. 儿童与青少年高血压的筛查诊疗——《中国高血压防治指南(2024年修订版)》解读[J]. 中华高血压杂志(中英文), 2025, 33(10): 901-905.
|
|
[12]
|
Afshin, A., Reitsma, M.B. and Murray, C.J.L. (2017) Health Effects of Overweight and Obesity in 195 Countries. The New England Journal of Medicine, 377, 1496-1497.
|
|
[13]
|
国家卫生健康委食品安全标准与监测评估司, 中国疾病预防控制中心营养与健康所, 成人肥胖食养指南编写专家组. 成人肥胖食养指南(2024年版) [J]. 卫生研究, 2024, 53(3): 347-351.
|
|
[14]
|
Schreiber, J.B. and Amin, M.E.K. (2025) Core Reporting Expectations for Quantitative Manuscripts Using Independent and Dependent T-Tests, One-Way ANOVA, OLS Regression, and Chi-Square. Currents in Pharmacy Teaching and Learning, 17, Article ID: 102462. [Google Scholar] [CrossRef]
|
|
[15]
|
Liu, B., O'Keefe, K., Gao, Y. and Yang, H. (2025) Residual Chi-Square Separation-Based High-Success-Rate Approach for Multiple GNSS Fault Exclusion. Aerospace Science and Technology, 167, Article ID: 110696. [Google Scholar] [CrossRef]
|
|
[16]
|
Alagoz, O., Srinivasan, S., Kim, I. and Kurt, M. (2022) MSR38 Can Logistic Regression (LOR) Better Predict the Significance of the Overall Survival (OS) from Surrogate Endpoints (SES) for Randomized Controlled Trials (RCTS) in Oncology? Insights from a Cross-Tumor Case Study. Value in Health, 25, S357. [Google Scholar] [CrossRef]
|
|
[17]
|
Wanyonyi, M., Morris, N.Z., Musyoka, M.F., et al. (2025) Predicting Coronary Heart Disease Using Classical Statistical Models: A Comparative Evaluation of Logistic Regression and Cox Proportional Hazards. IAENG International Journal of Applied Mathematics, 55, 4173-4190.
|
|
[18]
|
Chin, S.O., Ha, I.G., Rhee, S.Y., Jeong, S.J., Chon, S., Kim, S.H., et al. (2020) Clinical Characteristics and Prevalence of Comorbidities According to Metformin Use in Korean Patients with Type 2 Diabetes. International Journal of Endocrinology, 2020, Article ID: 9879517. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Morton, S., Cubillos, A., Saunders, M.B. and Chandler, E. (2025) Implementation of Vancomycin Area under the Curve Therapeutic Drug Monitoring: Evaluation of Procedural Changes at a Multihospital Community Health System. American Journal of Health-System Pharmacy, 82, zxaf289. [Google Scholar] [CrossRef]
|
|
[20]
|
Nazimek-Siewniak, B., Moczulski, D. and Grzeszczak, W. (2002) Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes: Results of Longitudinal Study Design. Journal of Diabetes and Its Complications, 16, 271-276. [Google Scholar] [CrossRef] [PubMed]
|